Company Overview - Oruka Therapeutics, Inc. is a biotechnology company focused on developing novel biologics aimed at treating chronic skin diseases, particularly plaque psoriasis [3] - The company's mission is to provide patients with significant freedom from chronic skin conditions by achieving high rates of complete disease clearance with infrequent dosing, potentially as little as once or twice a year [3] Nasdaq Biotechnology Index Inclusion - Oruka Therapeutics is expected to be added to the Nasdaq Biotechnology Index (NBI), effective prior to market open on December 23, 2024 [1] - The NBI tracks the performance of securities listed on The Nasdaq Stock Market that are classified as biotechnology or pharmaceutical companies, with specific eligibility requirements including minimum market capitalization and average daily trading volume [2]
Oruka Therapeutics to be Added to the Nasdaq Biotechnology Index (NBI)